The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
2021 · Signal Transduction and Targeted Therapy · 338 citations
https://doi.org/10.1038/s41392-021-00659-4
B
Bo Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
3.9K
Citations
38
h-index
60
i10-index
Bo Kong is an academic researcher from Heidelberg University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Epigenetics and DNA Methylation. The author has an h-index of 38, co-authored 122 publications.
ORCID: 0000-0002-5281-9603Papers by this author
worksNext-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer
2015 · Molecular Cancer · 254 citations
https://doi.org/10.1186/s12943-015-0358-5
Erratum to: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer
2015 · Molecular Cancer · 206 citations
https://doi.org/10.1186/s12943-015-0401-6
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling
2015 · Gut · 112 citations
https://doi.org/10.1136/gutjnl-2014-307616
SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism
2018 · Neoplasia · 102 citations
https://doi.org/10.1016/j.neo.2018.03.008
Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype
2012 · Molecular Cancer · 57 citations
https://doi.org/10.1186/1476-4598-11-19
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat